| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |